We are live on ! Find out more
DGI

Disciplined Growth Investors Portfolio holdings

AUM $4.89B
1-Year Est. Return 33.85%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+33.85%
3 Year Est. Return
+189.56%
5 Year Est. Return
+214.46%
10 Year Est. Return
+1,077.2%
AUM
$5.24B
AUM Growth
+$304M
Cap. Flow
+$203M
Cap. Flow %
3.88%
Top 10 Hldgs %
36.59%
Holding
84
New
4
Increased
63
Reduced
12
Closed
1

Top Buys

Rank Stock Value
1
PRLB icon
Protolabs
PRLB
+$56.4M
2
PLXS icon
Plexus
PLXS
+$42M
3
LGIH icon
LGI Homes
LGIH
+$40.8M
4
SMCI icon
Super Micro Computer
SMCI
+$29.9M
5
SNBR
Sleep Number
SNBR
+$13.3M

Top Sells

Rank Stock Value
1
MIDD icon
Middleby
MIDD
+$49.8M
2
FDS icon
Factset
FDS
+$28.3M
3
KRNT icon
Kornit Digital
KRNT
+$19M
4
MANH icon
Manhattan Associates
MANH
+$18.3M
5
INFO
IHS Markit Ltd. Common Shares
INFO
+$3.29M

Sector Composition

Rank Sector Weight
1 Technology 44.58%
2 Consumer Discretionary 20.79%
3 Industrials 13.57%
4 Healthcare 9.28%
5 Energy 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPSC icon
51
SPS Commerce
SPSC
$2.7B
$20.8M 0.4%
208,623
+15,720
+8% +$1.55M
CEVA icon
52
CEVA Inc
CEVA
$859M
$20.6M 0.39%
434,919
+47,038
+12% +$2.32M
MANH icon
53
Manhattan Associates
MANH
$11.4B
$17.2M 0.33%
118,995
-137,267
-54% -$18.3M
CLB icon
54
Core Laboratories
CLB
$570M
$17.1M 0.33%
438,193
+624
+0.1% +$22.4K
FDS icon
55
Factset
FDS
$10.1B
$14.3M 0.27%
42,733
-86,576
-67% -$28.3M
MLKN icon
56
MillerKnoll
MLKN
$1.62B
$13.8M 0.26%
293,419
+28,369
+11% +$1.28M
RDHL
57
Redhill Biopharma
RDHL
$3.65M
$13.6M 0.26%
1,976
+147
+8% +$1.01M
KRNT icon
58
Kornit Digital
KRNT
$815M
$12.8M 0.25%
103,353
-180,275
-64% -$19M
CFR icon
59
Cullen/Frost Bankers
CFR
$10.3B
$12.8M 0.24%
114,175
+2,134
+2% +$249K
GEOS icon
60
Geospace Technologies
GEOS
$69.2M
$12.2M 0.23%
1,512,658
+150,687
+11% +$1.24M
SRI icon
61
Stoneridge
SRI
$193M
$11.5M 0.22%
388,192
+243,064
+167% +$7.7M
TVRD
62
Tvardi Therapeutics
TVRD
$22.1M
$9.63M 0.18%
18,746
+2,260
+14% +$1.43M
ZUMZ icon
63
Zumiez
ZUMZ
$322M
$9.18M 0.18%
187,283
+18,906
+11% +$849K
PRO
64
DELISTED
PROS Holdings
PRO
$6.8M 0.13%
149,183
+11,485
+8% +$508K
CHRS icon
65
Coherus Oncology
CHRS
$187M
$6.29M 0.12%
454,424
+45,581
+11% +$646K
EPAY
66
DELISTED
Bottomline Technologies Inc
EPAY
$5.92M 0.11%
159,749
+15,461
+11% +$637K
OSPN icon
67
OneSpan
OSPN
$601M
$4.84M 0.09%
189,699
-39,209
-17% -$1.02M
CASA
68
DELISTED
Casa Systems, Inc. Common Stock
CASA
$4.4M 0.08%
495,972
+53,922
+12% +$478K
MDXG icon
69
MiMedx Group
MDXG
$630M
$4.16M 0.08%
332,313
+58,082
+21% +$629K
SSYS icon
70
Stratasys
SSYS
$782M
$2.9M 0.06%
112,045
+11,140
+11% +$254K
NUVA
71
DELISTED
NuVasive, Inc.
NUVA
$2.63M 0.05%
38,874
+6,298
+19% +$430K
FTK icon
72
Flotek Industries
FTK
$1.41B
$2.4M 0.05%
231,278
+24,021
+12% +$259K
AAPL icon
73
Apple
AAPL
$4.45T
$443K 0.01%
3,237
+232
+8% +$30.1K
JPM icon
74
JPMorgan Chase
JPM
$962B
$326K 0.01%
2,096
+181
+9% +$28.4K
EMR icon
75
Emerson Electric
EMR
$91.7B
$318K 0.01%
3,300
-1,200
-27% -$113K
1 2
3
4

Similar funds

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
BMO
Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Disciplined Growth Investors's Q2 2021 Portfolio in Review

As of Q2 2021, Disciplined Growth Investors held 84 positions worth $5.24B, up 6.2% from $4.93B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Disciplined Growth Investors deployed $203M of net new capital in Q2 2021, opening 4 new positions and adding to 63 existing holdings. Its largest new stake was Microsoft: 1,120 shares worth $303K.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Middleby, an estimated $49.8M trimmed.

  • Disciplined Growth Investors's largest Q2 2021 buy was Microsoft: 1,120 shares worth $303K.
  • Disciplined Growth Investors added most to Protolabs in Q2 2021, an estimated $56.4M increase.
  • Disciplined Growth Investors's biggest Q2 2021 reduction was Middleby, cutting an estimated $49.8M.
  • Disciplined Growth Investors fully exited Eli Lilly in Q2 2021, selling an estimated $226K.
  • Disciplined Growth Investors's ten largest holdings make up 37% of its $5.24B portfolio in Q2 2021.
  • Disciplined Growth Investors opened 4 new positions and closed 1 in Q2 2021.
  • Disciplined Growth Investors's portfolio value rose 6.2% quarter-over-quarter to $5.24B.

Based on Disciplined Growth Investors's 13F filing for Q2 2021, filed 16 Aug 2021.